DalCor Pharmaceuticals: DalCor Pharmaceuticals is pioneering precision medicine for patients with cardiovascular disease. By combining genetic and clinical insights, the company’s development program, dalcetrapib, is intended to reduce fatal and non-fatal myocardial infarction (MI) following a recent acute coronary syndrome and deliver superior cardiovascular outcome in a specific genetic subset of patients.
Company Details
- Employees
- 18
- Founded
- -
- Address
- 2001 Boulevard Robert-Bourassa, Montreal,québec H3a 2a6,canada
- Phone
- (514)564-6474
- in****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- dalcorpharma.com
- HQ
- Montreal, Québec
Dalcor Pharmaceuticals Questions
Dalcor Pharmaceuticals's helpline number is (514)564-6474
Dalcor Pharmaceuticals's website is dalcorpharma.com
Dalcor Pharmaceuticals's LinkedIn profile is https://ca.linkedin.com/company/dalcor-pharmaceuticals
Dalcor Pharmaceuticals has
18 employees.
View email and phone details for 18
employees at Dalcor Pharmaceuticals.
Dalcor Pharmaceuticals's industry is
Biotechnology Research
Dalcor Pharmaceuticals's top competitors are
Repare Therapeutics,
Knight Therapeutics,
Evah - Evolution For Animal Health,
Laurent Pharmaceuticals,
Thryv Therapeutics Inc.,
Alethia Biotherapeutics Inc.,
Inversago Pharma,
Valeo Pharma,
Epitopea,
Giiant Pharma Inc..
Dalcor Pharmaceuticals's support email address is info@Dalcorpharma.com
Dalcor Pharmaceuticals's categories are Biotechnology Research
Dalcor Pharmaceuticals's founding year is 2015
